Our results demonstrate that this drug inhibits cell proliferation and induces apoptosis on AML models and primary blasts by the selective inhibition of the PI3K/Akt/mTOR pathway activity, while not affecting normal cells. Here, AKT1 is linked to acute myeloid leukemia.